COVID-19 severe or critically | |
COVID-19 (hospitalized or not) | |
anti-interleukin-6 | |
tocilizumab | Hong Zhao |
5366 | Rimland, 2020 | 2 | 30 | 0 | excluded | not a RCT | risk of bias not avaialble |
5523 | Toniati, 2020 | 2 | 99 | 0 | excluded | not a RCT | risk of bias not avaialble |
5526 | Price, 2020 | 2 | 13 | 0 | excluded | not a RCT | risk of bias not avaialble |